Phospholipase C-γ1 is required for the epidermal growth factor receptor-induced squamous cell carcinoma cell mitogenesis

被引:36
作者
Xie, Zhongjian [1 ,3 ]
Chen, Ying [2 ]
Liao, Er-Yuan [3 ]
Jiang, Yi [4 ]
Liu, Fu-You [5 ]
Pennypacker, Sally D. [1 ]
机构
[1] Univ Calif San Francisco, No Calif Inst Res & Educ, Vet Affairs Med Ctr, Endocrine Unit, San Francisco, CA 94121 USA
[2] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China
[3] Cent S Univ, Xiangya Hosp 2, Inst Metab & Endocrinol, Changsha 410011, Hunan, Peoples R China
[4] Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha 410011, Hunan, Peoples R China
[5] Cent S Univ, Xiangya Hosp 2, Res Inst Nephrol, Div Nephrol, Changsha 410011, Hunan, Peoples R China
基金
美国国家卫生研究院;
关键词
Epidermal growth factor receptor; Phospholipase C-gamma 1; Mitogenesis; Squamous cell carcinoma; HUMAN KERATINOCYTE DIFFERENTIATION; EGF RECEPTOR; ELEVATED CONTENT; C ACTIVITY; ACTIVATION; IMMUNOREACTIVITY; OVEREXPRESSION; MESSENGER; MEMBRANE; INVASION;
D O I
10.1016/j.bbrc.2010.05.103
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The epidermal growth factor receptor (EGFR) is a key driver in the process of squamous cell carcinoma (SCC) cell mitogenesis. Phospholipase C-gamma 1 (PLC-gamma 1) is a downstream target of EGFR signaling, but the role and necessity of PLC-gamma 1 in EGFR-induced cell mitogenesis remain unclear. In the present study, we report an elevated expression of PLC-gamma 1 in human SCC biopsies relative to adjacent normal epidermis, and in human SCC cell lines compared to normal human keratinocytes. EGFR-induced SCC cell mitogenesis was blocked by small interfering RNA knockdown of PLC-gamma 1. However, inhibition of the catalytic activity of phospholipase C had no effect on EGFR-induced SCC cell mitogenesis. In response to the EGFR ligand epidermal growth factor (EGF), PLC-gamma 1 was translocated not only to the plasma membrane but also to the nucleus. These data suggest that PLC-gamma 1 is required for EGFR-induced SCC cell mitogenesis and the mitogenic function of PLC-gamma 1 is independent of its lipase activity. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:296 / 300
页数:5
相关论文
共 31 条
[1]   ELEVATED CONTENT OF THE TYROSINE KINASE SUBSTRATE PHOSPHOLIPASE C-GAMMA-1 IN PRIMARY HUMAN BREAST CARCINOMAS [J].
ARTEAGA, CL ;
JOHNSON, MD ;
TODDERUD, G ;
COFFEY, RJ ;
CARPENTER, G ;
PAGE, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10435-10439
[2]   Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma [J].
Bei, R ;
Pompa, G ;
Vitolo, D ;
Moriconi, E ;
Ciocci, L ;
Quaranta, M ;
Frati, L ;
Kraus, MH ;
Muraro, R .
JOURNAL OF PATHOLOGY, 2001, 195 (03) :343-348
[3]   INOSITOL TRISPHOSPHATE, A NOVEL 2ND MESSENGER IN CELLULAR SIGNAL TRANSDUCTION [J].
BERRIDGE, MJ ;
IRVINE, RF .
NATURE, 1984, 312 (5992) :315-321
[4]   EPIDERMAL GROWTH-FACTOR RECEPTOR-MEDIATED CELL MOTILITY - PHOSPHOLIPASE-C ACTIVITY IS REQUIRED, BUT MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVITY IS NOT SUFFICIENT FOR INDUCED CELL-MOVEMENT [J].
CHEN, P ;
XIE, H ;
SEKAR, MC ;
GUPTA, K ;
WELLS, A .
JOURNAL OF CELL BIOLOGY, 1994, 127 (03) :847-857
[5]   EGF receptor ligands [J].
Harris, RC ;
Chung, E ;
Coffey, RJ .
EXPERIMENTAL CELL RESEARCH, 2003, 284 (01) :2-13
[6]   AN SH3 DOMAIN IS REQUIRED FOR THE MITOGENIC ACTIVITY OF MICROINJECTED PHOSPHOLIPASE C-GAMMA-1 [J].
HUANG, PS ;
DAVIS, L ;
HUBER, H ;
GOODHART, PJ ;
WEGRZYN, RE ;
OLIFF, A ;
HEIMBROOK, DC .
FEBS LETTERS, 1995, 358 (03) :287-292
[7]   GENE AMPLIFICATION AND OVEREXPRESSION OF EGF RECEPTOR IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK [J].
ISHITOYA, J ;
TORIYAMA, M ;
OGUCHI, N ;
KITAMURA, K ;
OHSHIMA, M ;
ASANO, K ;
YAMAMOTO, T .
BRITISH JOURNAL OF CANCER, 1989, 59 (04) :559-562
[8]   Epidermal growth factor signaling and mitogenesis in Plcg1 null mouse embryonic fibroblasts [J].
Ji, GS ;
Ermini, S ;
Baulida, J ;
Sun, FL ;
Carpenter, G .
MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (04) :749-757
[9]   Epidermal growth factor receptor immunoreactivity in human laryngeal squamous cell carcinoma [J].
Lee, CS ;
Redshaw, A ;
Boag, G .
PATHOLOGY, 1997, 29 (03) :251-254
[10]  
Maiorano E, 1998, J PATHOL, V185, P167